Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schaaf

Showing results (151-160 of 196) with videos related to

Pageof 20
Sort By:
Antimicrobial Agents and Chemotherapy|October 5, 2011
Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendationsS Thee, J A Seddon, P R Donald, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 29, 2009
Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosisH S Schaaf, T C Victor, A Venter, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 14, 2004
The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy eraB J Marais, R P Gie, H S Schaaf, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 15, 2004
The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy eraB J Marais, R P Gie, H S Schaaf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2003
Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected childrenA C Hesseling, H S Schaaf, W A Hanekom, et al.
European Journal of Clinical Pharmacology|May 17, 2007
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazidP R Donald, D P Parkin, H I Seifart, et al.
The Pediatric Infectious Disease Journal|May 8, 2004
Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected childrenAnneke C Hesseling, Hendrik S Schaaf, Thomas Victor, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2023
Children´s priorities to improve the acceptability of MDR-TB treatment: qualitative data from South AfricaD T Wademan, L Viljoen, S Jacobs, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 8, 2009
BCG vaccination in South African HIV-exposed infants--risks and benefitsA C Hesseling, J Caldwell, M F Cotton, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 29, 2020
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is neededH S Schaaf, K du Preez, M Kruger, et al.
Pageof 20

Showing results (151-160 of 196) with videos related to

Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|October 5, 2011
Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendationsS Thee, J A Seddon, P R Donald, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 29, 2009
Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosisH S Schaaf, T C Victor, A Venter, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 14, 2004
The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy eraB J Marais, R P Gie, H S Schaaf, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 15, 2004
The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy eraB J Marais, R P Gie, H S Schaaf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2003
Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected childrenA C Hesseling, H S Schaaf, W A Hanekom, et al.
European Journal of Clinical Pharmacology|May 17, 2007
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazidP R Donald, D P Parkin, H I Seifart, et al.
The Pediatric Infectious Disease Journal|May 8, 2004
Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected childrenAnneke C Hesseling, Hendrik S Schaaf, Thomas Victor, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2023
Children´s priorities to improve the acceptability of MDR-TB treatment: qualitative data from South AfricaD T Wademan, L Viljoen, S Jacobs, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 8, 2009
BCG vaccination in South African HIV-exposed infants--risks and benefitsA C Hesseling, J Caldwell, M F Cotton, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 29, 2020
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is neededH S Schaaf, K du Preez, M Kruger, et al.
Pageof 20